Staging systems in hepatocellular carcinoma, HPB (Oxford), vol.7, pp.35-41, 2005. ,
Sorafenib in advanced hepatocellular carcinoma, N Engl J Med, vol.359, pp.378-390, 2008. ,
clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, vol.56, pp.908-943, 2012. ,
Hepatic artery embolization in 120 patients with unresectable hepatoma, Radiology, vol.148, pp.397-401, 1983. ,
The blood supply of neoplasms in the liver, Am J Pathol, vol.30, pp.969-977, 1954. ,
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial, Lancet, vol.359, pp.1734-1739, 2002. ,
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution, Hepatology, vol.27, pp.1578-1583, 1998. ,
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival, Hepatology, vol.37, pp.429-442, 2003. ,
Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies, Cardiovasc Intervent Radiol, vol.30, pp.6-25, 2007. ,
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis, Ann Surg, vol.226, pp.688-701, 1997. ,
Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation, Ann Surg, vol.248, pp.617-625, 2008. ,
Excellent outcome following downstaging of hepatocellular carcinoma prior to liver transplantation: an intention-totreat analysis, Hepatology, vol.48, pp.819-827, 2008. ,
Dynamic study of iodized oil in the liver and blood supply to hepatic tumors. An experimental investigation in several animal species, Acta Radiol Suppl, vol.408, pp.1-25, 1996. ,
Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization, Cardiovasc Intervent Radiol, vol.24, pp.383-387, 2001. ,
Modification of arterial and portal hemodynamics after injection of iodized oils and different emulsions of iodized oils in the hepatic artery: an experimental study, J Vasc Interv Radiol, vol.9, pp.305-310, 1998. ,
Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma, AJR Am J Roentgenol, vol.175, pp.699-704, 2000. ,
Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session ,
, Gastroenterol Clin Biol, vol.26, pp.728-734, 2002.
Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma, Aliment Pharmacol Ther, vol.35, pp.1343-1350, 2012. ,
Ethiodized oil uptake does not predict doxorubicin drug delivery after chemoembolization in VX2 liver tumors, J Vasc Interv Radiol, vol.23, pp.265-273, 2012. ,
Techniques to Form a Suitable Lipiodol-Epirubicin Emulsion by Using 3-Way Stopcock Methods in Transarterial Chemoembolization for Liver Tumor, J Vasc Interv Radiol, 2017. ,
New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer, Clin Cancer Res, vol.12, pp.2563-2567, 2006. ,
Drug-loaded microspheres for the treatment of liver cancer: review of current results, Cardiovasc Intervent Radiol, vol.31, pp.468-476, 2008. ,
Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan, J Vasc Interv Radiol, vol.21, pp.1084-1090, 2010. ,
Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity, Cancer Biother Radiopharm, vol.27, pp.149-155, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00867018
Circulatory alterations induced by intraarterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study, Radiology, vol.194, pp.165-170, 1995. ,
Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study, Radiology, vol.201, pp.731-735, 1996. ,
Simulation model based on nonnewtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug, Cardiovasc Intervent Radiol, vol.23, pp.285-290, 2000. ,
Confirmation of drug delivery after liver chemoembolization: direct tissue doxorubicin measurement by UHPLCMS-MS, Biomed Chromatogr, vol.26, pp.1529-1533, 2012. ,
Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion, Cardiovasc Intervent Radiol, 2015. ,
Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data, Hepatology, vol.64, pp.106-116, 2016. ,
Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil, J Vasc Interv Radiol, vol.18, pp.365-376, 2007. ,
Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival, Eur Radiol, vol.21, pp.1719-1726, 2011. ,
,
, Hepatic Arteriography in Chemoembolization for Hepatocellular Carcinoma: Performance Depicting Tumors and Tumor Feeders, Cardiovasc Intervent Radiol, vol.38, pp.1218-1230, 2015.
Cone-Beam CT Angiography for Determination of Tumor-Feeding Vessels During Chemoembolization of Liver Tumors: Comparison of Conventional and Dedicated-Software Analysis, J Vasc Interv Radiol, 2015. ,
Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads, PLoS One, vol.9, p.115898, 2014. ,
Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors, Hepatology, vol.19, pp.1115-1123, 1994. ,
Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center, Radiology, vol.214, pp.349-357, 2000. ,
Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma, Cardiovasc Intervent Radiol, vol.38, pp.1548-1556, 2015. ,
Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model, Radiology, vol.263, pp.714-722, 2012. ,
Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin, Eur Radiol, vol.26, pp.601-609, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01436674
Stabilization Improves Theranostic Properties of Lipiodol(R)-Based Emulsion During Liver Trans-arterial Chemo-embolization in a VX2 Rabbit Model, Cardiovasc Intervent Radiol, vol.40, pp.907-913, 2017. ,
Dynamics of Transitional Phase Inversion Emulsification: Effect of Addition Time on the Type of Inversion and Drop Size, Ind. Eng. Chem. Res, vol.49, pp.7631-7637, 2019. ,
Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review, Crit Rev Oncol Hematol, vol.88, pp.530-549, 2013. ,
Separation of Solids in the Surface-layers of Solutions and 'Suspension' (Observations on surface-membranes, Bubbles, Emulsions, and Mechanical Cooagulation). Prliminary Account, Proc. R. Soc. Lond, vol.72, pp.156-164, 1903. ,
, J Chem Soc, p.91, 1907.
Emulsions stabilized with solid nanoparticles: Pickering emulsions ,
URL : https://hal.archives-ouvertes.fr/hal-02044597
, Coll. Surf. A, vol.439, pp.23-34, 2013.
Poly(lactic-co-glycolic acid) as a particulate emulsifier, J Colloid Interface Sci, vol.375, pp.142-147, 2012. ,
Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty, Circulation, vol.94, pp.1441-1448, 1996. ,
Synthesis and characterization of PLGA nanoparticles, J Biomater Sci Polym Ed, vol.17, pp.247-289, 2006. ,
PLGA nanoparticles in drug delivery: the state of the art, Crit Rev Ther Drug Carrier Syst, vol.21, pp.387-422, 2004. ,
Phase inversion of particle-stabilised perfume oil-water emulsions: experiment and theory, Phys Chem Chem Phys, vol.12, pp.11954-11966, 2010. ,
Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery, Am J Clin Pathol, vol.90, pp.536-544, 1988. ,
Emulsions stabilized with organic solid particles, Coll. Surf. A, vol.413, pp.252-259, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-02044599
,
, Pickering Emulsions Stabilised by Biodegradable Particles Offer a Double Level of Controlled Delivery of Hydrophobic Drugs, Adv Dermatological Sci, vol.20, pp.143-156, 2014.
In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma, Mol Pharm, vol.14, pp.448-458, 2017. ,
Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure, Ann Surg Oncol, vol.15, pp.219-226, 2008. ,
DOI : 10.1245/s10434-007-9581-7
Oxaliplatin-based chemotherapy: a new option in advanced hepatocellular carcinoma. a systematic review and pooled analysis, Clin Oncol (R Coll Radiol), vol.26, pp.488-496, 2014. ,
DOI : 10.1016/j.clon.2014.04.031
Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer, J Clin Oncol, vol.23, pp.4881-4887, 2005. ,
Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes, Cancer, vol.113, pp.1614-1622, 2008. ,
Parameters for Stable Water-in-Oil Lipiodol Emulsion for Liver Trans-Arterial Chemo-Eembolization, Cardiovasc Intervent Radiol, 2017. ,
Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model, Anticancer Drugs, vol.15, pp.647-650, 2004. ,
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C, J Hepatol, vol.59, pp.81-88, 2013. ,
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial, Lancet, vol.389, pp.2492-2502, 2017. ,
Intratumoral immunization: a new paradigm for cancer therapy, Clin Cancer Res, vol.20, pp.1747-1756, 2014. ,
Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects, Clin Cancer Res, vol.19, pp.5381-5389, 2013. ,
Depleting tumor-specific Tregs at a single site eradicates disseminated tumors, J Clin Invest, vol.123, pp.2447-2463, 2013. ,
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy, Ann Oncol, vol.27, pp.1482-1492, 2016. ,
Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study, Lancet Oncol, vol.11, pp.155-164, 2010. ,